Cedar Mountain Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7K Buy
175
+34
+24% +$2.74K ﹤0.01% 429
2026
Q1
$12.2K Sell
141
-1
-0.7% -$96 ﹤0.01% 408
2025
Q4
$13.6K Sell
142
-25
-15% -$2.43K ﹤0.01% 226
2025
Q3
$15.9K Buy
167
+117
+234% +$10.8K ﹤0.01% 208
2025
Q2
$4.36K Hold
50
﹤0.01% 278
2025
Q1
$4.49K Hold
50
﹤0.01% 255
2024
Q4
$3.99K Hold
50
﹤0.01% 273
2024
Q3
$4.5K Hold
50
﹤0.01% 254
2024
Q2
$3.94K Sell
50
-16
-24% -$1.31K ﹤0.01% 246
2024
Q1
$5.75K Buy
66
+50
+313% +$4.27K ﹤0.01% 218
2023
Q4
$1.32K Buy
+16
New +$1.22K ﹤0.01% 281
2022
Q2
Sell
-63
Closed -$7K 326
2022
Q1
$7K Hold
63
﹤0.01% 213
2021
Q4
$7K Hold
63
﹤0.01% 214
2021
Q3
$8K Buy
+63
New +$8.15K ﹤0.01% 193

Other funds holding MDT

Cedar Mountain Advisors's MDT Position: Q2 2026 in Review

Cedar Mountain Advisors increased its Medtronic (MDT) stake by 24% in Q2 2026, buying an estimated $2.74K and bringing the position to 175 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #429.

Cedar Mountain Advisors first reported a position in MDT in Q3 2021 and has held it in 14 quarters since. The position peaked at $15.9K in Q3 2025. 469 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Cedar Mountain Advisors held 175 shares of Medtronic worth $13.7K as of Q2 2026.
  • Cedar Mountain Advisors bought 34 Medtronic shares in Q2 2026, an estimated $2.74K.
  • Medtronic made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q2 2026, its #429 holding.
  • Cedar Mountain Advisors first reported a position in Medtronic in Q3 2021 and has held it in 14 quarters since.
  • Cedar Mountain Advisors's Medtronic position peaked at $15.9K in Q3 2025.
  • 469 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.